Larry Tankel: We believe a variety of businesses including healthcare, financials, advertising and industrials will be impacted to varying degrees. For example, the healthcare industry could see significant disruption through the advancement of data analytics, which should help improve the quality, efficiency and outcome of patient diagnoses while also reducing costs. Gene sequencing has become exponentially faster, more efficient and cheaper, leading to new possibilities in DNA sequencing and diagnosis. In 2000, the Human Genome project was completed in 13 years at a total cost of $3.8 billion, but today the human genome can be sequenced for approximately $1,000 per genome in less than three hours.
Steve Waxman: The insurance industry could see significant disruption. Consider ‘telematics,’ a technology for collecting data on driver behaviors, including speed and abruptness of braking. Most large European motor insurers are now offering the technology, which can be a standalone device or function as a phone app, as a way for safer drivers to get better prices. In the near term, this technology benefits early adapters and likely improves loss ratios and therefore margins. In the long term, the initiative could be a negative for the sector if it keeps premium rates depressed, especially since insurers are more likely to withhold discounts for bad drivers rather than increase prices. Some insurance startups are even moving towards providing ‘on-demand’ insurance for single items, which is based on their ability to use big data. To some extent, every insurer is going to have to be a software and analytics company in the future.